A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
Sira Nanthapisal, Thanyawee Puthanakit, Peera Jaru-Ampornpan, Rapisa Nantanee, Pimpayao Sodsai, Orawan Himananto, Jiratchaya Sophonphan, Pintip Suchartlikitwong, Narin Hiransuthikul, Pornpimon Angkasekwinai, Auchara Tangsathapornpong, Nattiya Hirankarn
Topics & Concepts
ReactogenicityImmunogenicityMedicineBooster doseRandomized controlled trialBooster (rocketry)Confidence intervalAntibodyInternal medicineGastroenterologyImmunologyImmunizationPhysicsAstronomySARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesHeparin-Induced Thrombocytopenia and Thrombosis